$1.31
2.34% yesterday
Nasdaq, Aug 12, 10:00 pm CET

Fluidigm Corporation Stock price

$1.31
+0.06 4.80% 1M
-0.05 3.32% 6M
-0.44 25.14% YTD
-0.28 17.61% 1Y
-0.45 25.57% 3Y
-6.21 82.58% 5Y
-11.71 89.94% 10Y
-12.71 90.66% 20Y
Nasdaq, Closing price Tue, Aug 12 2025
+0.03 2.34%

Key metrics

Basic
Market capitalization
$486.2m
Enterprise Value
$228.4m
Net debt
positive
Cash
$258.1m
Shares outstanding
379.1m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
2.9 | 2.8
EV/Sales
1.4 | 1.3
EV/FCF
negative
P/B
1.1
Financial Health
Equity Ratio
77.1%
Return on Equity
-39.2%
ROCE
-24.1%
ROIC
-43.3%
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$169.7m | $170.8m
EBITDA
$-110.5m | $-60.6m
EBIT
$-126.3m | $-114.9m
Net Income
$-132.8m | $-105.3m
Free Cash Flow
$-123.9m
Growth (TTM | estimate)
Revenue
33.9% | -2.1%
EBITDA
-58.7% | 48.6%
EBIT
-46.3% | 14.8%
Net Income
2.4% | 43.1%
Free Cash Flow
-24.0%
Margin (TTM | estimate)
Gross
47.0%
EBITDA
-65.1% | -35.5%
EBIT
-74.4%
Net
-78.2% | -61.6%
Free Cash Flow
-73.0%
More
EPS
$-0.4
FCF per Share
$-0.3
Short interest
5.5%
Employees
816
Rev per Employee
$210.0k
Show more

Is Fluidigm Corporation a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,027 stocks worldwide.

Fluidigm Corporation Stock Analysis

Unlock Scores for Free

Analyst Opinions

7 Analysts have issued a Fluidigm Corporation forecast:

5x Buy
71%
2x Hold
29%

Analyst Opinions

7 Analysts have issued a Fluidigm Corporation forecast:

Buy
71%
Hold
29%

Financial data from Fluidigm Corporation

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
170 170
34% 34%
100%
- Direct Costs 90 90
39% 39%
53%
80 80
28% 28%
47%
- Selling and Administrative Expenses 148 148
31% 31%
87%
- Research and Development Expense 58 58
63% 63%
34%
-110 -110
59% 59%
-65%
- Depreciation and Amortization 16 16
5% 5%
9%
EBIT (Operating Income) EBIT -126 -126
46% 46%
-74%
Net Profit -133 -133
2% 2%
-78%

In millions USD.

Don't miss a Thing! We will send you all news about Fluidigm Corporation directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Fluidigm Corporation Stock News

Neutral
GlobeNewsWire
one day ago
SOUTH SAN FRANCISCO, Calif., Aug. 11, 2025 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (NASDAQ: LAB) (the “Company” or “Standard BioTools”) today announced financial results for the second quarter ended June 30, 2025. Standard BioTools will no longer host its second quarter 2025 earnings call, previously scheduled for Monday, August 11 at 4:30 p.m. ET.
Neutral
GlobeNewsWire
6 days ago
PRECISE-SG100K will run 100,000 samples as part of an effort to transform precision health and medicine Reinforces SomaScan's strategic position in the high-impact biobank segment and its increasing role in leading global health initiatives SOUTH SAN FRANCISCO, Calif., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (NASDAQ: LAB) today announced that the Precision Health Research, Sing...
Neutral
GlobeNewsWire
22 days ago
SOUTH SAN FRANCISCO, Calif., July 21, 2025 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (NASDAQ: LAB) today announced that it will report second quarter 2025 financial results on Monday, August 11, 2025, after market close. The company will host a conference call and webcast on the same day at 4:30 p.m. ET to discuss its financial results and operational progress.
More Fluidigm Corporation News

Company Profile

Fluidigm Corp. is engaged in the development, manufacture and marketing of biotechnology tools fro life sciences research. It sells preparatory and analytical instruments for mass cytometry, polymerase chain reaction, library prep, single cell genomics; and consumables including integrated fluidic circuits (IFCs), assays, and reagents. The company was founded by Stephen R. Quake and Gajus V. Worthington on May 19, 1999 and is headquartered in South San Francisco, CA.

Head office United States
CEO Michael Egholm
Employees 816
Founded 1999
Website www.standardbio.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today